| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 225 | 2024 | 12240 | 7.270 |
Why?
|
| Insulin Resistance | 84 | 2023 | 3985 | 4.100 |
Why?
|
| Blood Glucose | 105 | 2024 | 6424 | 3.760 |
Why?
|
| Fasting | 47 | 2022 | 1606 | 3.160 |
Why?
|
| Insulin | 74 | 2023 | 6599 | 2.890 |
Why?
|
| Polymorphism, Single Nucleotide | 124 | 2024 | 16047 | 2.780 |
Why?
|
| Genome-Wide Association Study | 93 | 2024 | 12807 | 2.250 |
Why?
|
| Diabetes Mellitus | 56 | 2023 | 5891 | 2.210 |
Why?
|
| Cardiovascular Diseases | 88 | 2024 | 15652 | 1.950 |
Why?
|
| Adiponectin | 24 | 2019 | 1119 | 1.770 |
Why?
|
| Genetic Variation | 46 | 2022 | 6610 | 1.640 |
Why?
|
| Genetic Predisposition to Disease | 79 | 2024 | 18071 | 1.590 |
Why?
|
| Obesity | 72 | 2023 | 13076 | 1.550 |
Why?
|
| Genotype | 53 | 2023 | 13024 | 1.400 |
Why?
|
| Diabetic Angiopathies | 13 | 2020 | 805 | 1.390 |
Why?
|
| Body Mass Index | 75 | 2023 | 13039 | 1.280 |
Why?
|
| Hyperglycemia | 21 | 2023 | 1393 | 1.240 |
Why?
|
| Albuminuria | 20 | 2013 | 660 | 1.200 |
Why?
|
| Risk Factors | 193 | 2024 | 74840 | 1.190 |
Why?
|
| Quantitative Trait Loci | 24 | 2021 | 2140 | 1.180 |
Why?
|
| Middle Aged | 326 | 2024 | 223009 | 1.110 |
Why?
|
| Resistin | 10 | 2012 | 174 | 1.100 |
Why?
|
| Glucose Intolerance | 15 | 2023 | 580 | 1.080 |
Why?
|
| Prediabetic State | 11 | 2023 | 548 | 1.040 |
Why?
|
| Male | 348 | 2024 | 363698 | 0.940 |
Why?
|
| Female | 374 | 2024 | 396112 | 0.920 |
Why?
|
| Humans | 516 | 2024 | 765968 | 0.910 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2021 | 541 | 0.890 |
Why?
|
| Genome, Human | 18 | 2021 | 4448 | 0.800 |
Why?
|
| Coronary Disease | 22 | 2023 | 5912 | 0.800 |
Why?
|
| Adult | 227 | 2024 | 223044 | 0.800 |
Why?
|
| Intra-Abdominal Fat | 10 | 2014 | 623 | 0.790 |
Why?
|
| Aged | 191 | 2024 | 171117 | 0.780 |
Why?
|
| Diabetes Complications | 11 | 2024 | 1316 | 0.760 |
Why?
|
| Genetic Loci | 19 | 2022 | 2631 | 0.740 |
Why?
|
| Glucose | 17 | 2023 | 4335 | 0.720 |
Why?
|
| Multifactorial Inheritance | 10 | 2024 | 1425 | 0.700 |
Why?
|
| Relief Work | 1 | 2022 | 132 | 0.690 |
Why?
|
| Gene Frequency | 23 | 2019 | 3624 | 0.670 |
Why?
|
| Cholesterol, HDL | 19 | 2021 | 1811 | 0.670 |
Why?
|
| Coronary Artery Disease | 17 | 2024 | 6544 | 0.660 |
Why?
|
| Insulin, Long-Acting | 3 | 2014 | 59 | 0.650 |
Why?
|
| Proinsulin | 6 | 2023 | 135 | 0.650 |
Why?
|
| Hypoglycemic Agents | 17 | 2020 | 3110 | 0.640 |
Why?
|
| Metabolomics | 3 | 2022 | 1668 | 0.630 |
Why?
|
| Hypertension | 35 | 2020 | 8626 | 0.630 |
Why?
|
| Incidence | 59 | 2024 | 21480 | 0.620 |
Why?
|
| Primary Health Care | 13 | 2024 | 4736 | 0.610 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 8 | 2016 | 282 | 0.610 |
Why?
|
| Patient Compliance | 14 | 2009 | 2692 | 0.600 |
Why?
|
| Phenotype | 41 | 2024 | 16721 | 0.600 |
Why?
|
| Cohort Studies | 90 | 2024 | 41649 | 0.600 |
Why?
|
| Massachusetts | 39 | 2014 | 8875 | 0.600 |
Why?
|
| Weight Gain | 6 | 2013 | 2355 | 0.580 |
Why?
|
| Glucose Tolerance Test | 22 | 2023 | 1180 | 0.570 |
Why?
|
| Genetic Association Studies | 12 | 2022 | 2741 | 0.560 |
Why?
|
| Insulin-Secreting Cells | 7 | 2020 | 898 | 0.550 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2021 | 558 | 0.550 |
Why?
|
| Diet | 24 | 2023 | 8086 | 0.540 |
Why?
|
| Triglycerides | 22 | 2021 | 2441 | 0.540 |
Why?
|
| Polymorphism, Genetic | 15 | 2022 | 4247 | 0.510 |
Why?
|
| Adipose Tissue | 8 | 2019 | 3312 | 0.490 |
Why?
|
| Acculturation | 1 | 2016 | 178 | 0.490 |
Why?
|
| Heart Diseases | 11 | 2014 | 2821 | 0.490 |
Why?
|
| Models, Genetic | 11 | 2022 | 3449 | 0.480 |
Why?
|
| Atherosclerosis | 6 | 2023 | 3424 | 0.470 |
Why?
|
| Alleles | 26 | 2022 | 6897 | 0.460 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 33 | 0.460 |
Why?
|
| Prevalence | 36 | 2022 | 15842 | 0.460 |
Why?
|
| Chromosome Mapping | 12 | 2018 | 4618 | 0.460 |
Why?
|
| Genetic Counseling | 4 | 2012 | 634 | 0.460 |
Why?
|
| C-Reactive Protein | 20 | 2022 | 3850 | 0.450 |
Why?
|
| Hyperinsulinism | 6 | 2015 | 402 | 0.450 |
Why?
|
| Life Style | 19 | 2022 | 3926 | 0.440 |
Why?
|
| Refugees | 1 | 2022 | 614 | 0.430 |
Why?
|
| Outpatient Clinics, Hospital | 3 | 2004 | 394 | 0.430 |
Why?
|
| Subcutaneous Fat | 4 | 2013 | 402 | 0.430 |
Why?
|
| Health Literacy | 2 | 2016 | 464 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2014 | 412 | 0.430 |
Why?
|
| Dyslipidemias | 6 | 2021 | 869 | 0.430 |
Why?
|
| Smoking Cessation | 3 | 2016 | 2084 | 0.420 |
Why?
|
| Genetic Linkage | 5 | 2008 | 2341 | 0.420 |
Why?
|
| Adiposity | 9 | 2020 | 1890 | 0.420 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2018 | 4348 | 0.420 |
Why?
|
| Mendelian Randomization Analysis | 8 | 2022 | 1044 | 0.420 |
Why?
|
| American Heart Association | 9 | 2010 | 1047 | 0.410 |
Why?
|
| Meta-Analysis as Topic | 13 | 2021 | 1370 | 0.410 |
Why?
|
| Longitudinal Studies | 33 | 2024 | 14751 | 0.410 |
Why?
|
| Odds Ratio | 29 | 2020 | 9649 | 0.410 |
Why?
|
| Disease Management | 4 | 2020 | 2535 | 0.400 |
Why?
|
| Aging | 14 | 2022 | 8731 | 0.400 |
Why?
|
| Aged, 80 and over | 54 | 2022 | 59489 | 0.400 |
Why?
|
| Lipids | 14 | 2021 | 3315 | 0.390 |
Why?
|
| Choristoma | 1 | 2013 | 206 | 0.380 |
Why?
|
| Prospective Studies | 50 | 2023 | 54802 | 0.380 |
Why?
|
| Cross-Sectional Studies | 55 | 2022 | 26318 | 0.380 |
Why?
|
| Risk Assessment | 24 | 2024 | 24282 | 0.370 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2016 | 1936 | 0.370 |
Why?
|
| Genetic Testing | 6 | 2012 | 3595 | 0.360 |
Why?
|
| Case-Control Studies | 39 | 2024 | 22223 | 0.360 |
Why?
|
| Diabetic Retinopathy | 6 | 2024 | 1299 | 0.360 |
Why?
|
| Electronic Health Records | 6 | 2024 | 4873 | 0.350 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 569 | 0.350 |
Why?
|
| Prostatic Hyperplasia | 5 | 2002 | 515 | 0.350 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2011 | 138 | 0.340 |
Why?
|
| Hypoglycemia | 2 | 2015 | 896 | 0.340 |
Why?
|
| Sweetening Agents | 4 | 2017 | 291 | 0.340 |
Why?
|
| United States | 70 | 2024 | 72903 | 0.330 |
Why?
|
| Follow-Up Studies | 37 | 2018 | 39193 | 0.330 |
Why?
|
| Interleukin-6 | 10 | 2022 | 3222 | 0.320 |
Why?
|
| Proportional Hazards Models | 25 | 2019 | 12509 | 0.320 |
Why?
|
| Linkage Disequilibrium | 12 | 2024 | 1997 | 0.320 |
Why?
|
| Vitamin D | 5 | 2018 | 3272 | 0.310 |
Why?
|
| Attitude to Health | 2 | 2009 | 2020 | 0.310 |
Why?
|
| Blood Pressure | 22 | 2018 | 8532 | 0.310 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2009 | 347 | 0.310 |
Why?
|
| Logistic Models | 27 | 2020 | 13266 | 0.310 |
Why?
|
| Predictive Value of Tests | 19 | 2021 | 15398 | 0.310 |
Why?
|
| Sex Factors | 28 | 2024 | 10603 | 0.310 |
Why?
|
| Nutrition Surveys | 11 | 2022 | 1741 | 0.300 |
Why?
|
| Magnesium | 4 | 2013 | 813 | 0.300 |
Why?
|
| Inflammation | 19 | 2014 | 10850 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2008 | 640 | 0.300 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 7 | 2013 | 152 | 0.290 |
Why?
|
| Stroke | 15 | 2021 | 9747 | 0.290 |
Why?
|
| Vitamin D Deficiency | 2 | 2018 | 1348 | 0.290 |
Why?
|
| Evidence-Based Medicine | 6 | 2023 | 3685 | 0.290 |
Why?
|
| Health Behavior | 7 | 2012 | 2650 | 0.280 |
Why?
|
| Creatinine | 11 | 2012 | 1915 | 0.280 |
Why?
|
| Physicians, Family | 1 | 2009 | 349 | 0.280 |
Why?
|
| Risk | 20 | 2020 | 9591 | 0.280 |
Why?
|
| Multivariate Analysis | 30 | 2018 | 12056 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2008 | 350 | 0.280 |
Why?
|
| E-Selectin | 4 | 2005 | 576 | 0.280 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 323 | 0.270 |
Why?
|
| Waist-Hip Ratio | 7 | 2021 | 520 | 0.270 |
Why?
|
| Linear Models | 16 | 2017 | 5876 | 0.270 |
Why?
|
| Genomic Imprinting | 3 | 2020 | 326 | 0.270 |
Why?
|
| Postprandial Period | 2 | 2006 | 319 | 0.260 |
Why?
|
| Feeding Behavior | 11 | 2017 | 3212 | 0.260 |
Why?
|
| Socioeconomic Factors | 13 | 2022 | 7838 | 0.260 |
Why?
|
| HIV Infections | 16 | 2024 | 17533 | 0.260 |
Why?
|
| Cholesterol, LDL | 13 | 2022 | 2393 | 0.260 |
Why?
|
| Social Support | 1 | 2016 | 2192 | 0.260 |
Why?
|
| Dietary Fats | 5 | 2019 | 2002 | 0.250 |
Why?
|
| Oxidative Stress | 5 | 2014 | 3141 | 0.250 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 1263 | 0.250 |
Why?
|
| Age Factors | 21 | 2017 | 18380 | 0.250 |
Why?
|
| Genetic Heterogeneity | 2 | 2010 | 735 | 0.250 |
Why?
|
| Sarcopenia | 2 | 2022 | 378 | 0.250 |
Why?
|
| Islets of Langerhans | 5 | 2024 | 1349 | 0.250 |
Why?
|
| Documentation | 2 | 2009 | 916 | 0.240 |
Why?
|
| Yogurt | 3 | 2017 | 71 | 0.240 |
Why?
|
| Population Groups | 2 | 2019 | 209 | 0.240 |
Why?
|
| Food Supply | 4 | 2018 | 544 | 0.240 |
Why?
|
| Endothelium, Vascular | 8 | 2012 | 4427 | 0.240 |
Why?
|
| Body Size | 5 | 2020 | 459 | 0.240 |
Why?
|
| TCF Transcription Factors | 4 | 2010 | 137 | 0.230 |
Why?
|
| Adipokines | 3 | 2017 | 308 | 0.230 |
Why?
|
| Aorta, Abdominal | 3 | 2013 | 596 | 0.230 |
Why?
|
| Body Composition | 7 | 2022 | 2439 | 0.230 |
Why?
|
| Health Surveys | 11 | 2021 | 4056 | 0.230 |
Why?
|
| Hemostasis | 4 | 2012 | 467 | 0.230 |
Why?
|
| Lod Score | 4 | 2008 | 598 | 0.230 |
Why?
|
| Minisatellite Repeats | 1 | 2004 | 162 | 0.220 |
Why?
|
| Beverages | 3 | 2017 | 819 | 0.220 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2024 | 95 | 0.220 |
Why?
|
| Body Fat Distribution | 3 | 2022 | 246 | 0.220 |
Why?
|
| Information Systems | 1 | 2006 | 400 | 0.220 |
Why?
|
| Subcutaneous Fat, Abdominal | 3 | 2010 | 91 | 0.210 |
Why?
|
| Inflammation Mediators | 3 | 2009 | 1884 | 0.210 |
Why?
|
| Waist Circumference | 9 | 2015 | 932 | 0.210 |
Why?
|
| Family Health | 4 | 2016 | 1253 | 0.210 |
Why?
|
| Cholesterol | 13 | 2017 | 2898 | 0.210 |
Why?
|
| Homeostasis | 11 | 2019 | 3336 | 0.210 |
Why?
|
| Outpatients | 3 | 2021 | 1595 | 0.210 |
Why?
|
| Neoplasms | 7 | 2016 | 22340 | 0.210 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2024 | 209 | 0.210 |
Why?
|
| Overweight | 9 | 2013 | 2444 | 0.210 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2022 | 326 | 0.210 |
Why?
|
| Myocardial Infarction | 6 | 2024 | 11499 | 0.200 |
Why?
|
| Poverty | 6 | 2021 | 2714 | 0.200 |
Why?
|
| Carbonated Beverages | 3 | 2016 | 209 | 0.200 |
Why?
|
| Hyperlipidemias | 8 | 2010 | 770 | 0.200 |
Why?
|
| Hypercholesterolemia | 5 | 2010 | 1149 | 0.200 |
Why?
|
| DNA Methylation | 4 | 2023 | 4424 | 0.190 |
Why?
|
| Polypharmacy | 1 | 2004 | 306 | 0.190 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1789 | 0.190 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2015 | 84 | 0.190 |
Why?
|
| Dairy Products | 2 | 2017 | 491 | 0.190 |
Why?
|
| Self Care | 4 | 2008 | 800 | 0.190 |
Why?
|
| Metabolic Diseases | 3 | 2008 | 687 | 0.190 |
Why?
|
| Internet | 2 | 2005 | 3106 | 0.190 |
Why?
|
| Sickle Cell Trait | 1 | 2022 | 86 | 0.190 |
Why?
|
| Leptin | 3 | 2020 | 1596 | 0.190 |
Why?
|
| Smoking | 19 | 2016 | 9081 | 0.190 |
Why?
|
| Income | 3 | 2020 | 1874 | 0.190 |
Why?
|
| Antihypertensive Agents | 5 | 2008 | 2033 | 0.190 |
Why?
|
| Cluster Analysis | 4 | 2014 | 2721 | 0.190 |
Why?
|
| Homocysteine | 3 | 2012 | 638 | 0.190 |
Why?
|
| Alanine Transaminase | 2 | 2022 | 607 | 0.180 |
Why?
|
| Drug Costs | 2 | 2006 | 1193 | 0.180 |
Why?
|
| Molecular Epidemiology | 3 | 2019 | 471 | 0.180 |
Why?
|
| Glucose-6-Phosphatase | 3 | 2016 | 70 | 0.180 |
Why?
|
| Kidney Failure, Chronic | 6 | 2012 | 2495 | 0.180 |
Why?
|
| Ankle Brachial Index | 2 | 2013 | 166 | 0.180 |
Why?
|
| Microvascular Angina | 1 | 2000 | 14 | 0.180 |
Why?
|
| Genomics | 6 | 2023 | 5929 | 0.180 |
Why?
|
| Health Status Indicators | 1 | 2006 | 966 | 0.180 |
Why?
|
| Educational Status | 5 | 2020 | 2513 | 0.180 |
Why?
|
| Carbohydrates | 2 | 2016 | 386 | 0.180 |
Why?
|
| Molecular Sequence Annotation | 3 | 2021 | 523 | 0.180 |
Why?
|
| Insurance Claim Review | 1 | 2005 | 746 | 0.180 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2022 | 2310 | 0.180 |
Why?
|
| Aldosterone | 6 | 2010 | 881 | 0.170 |
Why?
|
| von Willebrand Factor | 3 | 2010 | 676 | 0.170 |
Why?
|
| Regression Analysis | 15 | 2018 | 6322 | 0.170 |
Why?
|
| Obesity, Abdominal | 3 | 2013 | 369 | 0.170 |
Why?
|
| Geriatrics | 2 | 2004 | 396 | 0.170 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 622 | 0.170 |
Why?
|
| Apolipoproteins E | 4 | 2005 | 1458 | 0.170 |
Why?
|
| Prostate-Specific Antigen | 3 | 2001 | 2464 | 0.170 |
Why?
|
| Area Under Curve | 4 | 2018 | 1638 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 1806 | 0.170 |
Why?
|
| Developing Countries | 3 | 2021 | 2911 | 0.160 |
Why?
|
| Blood Chemical Analysis | 1 | 2001 | 433 | 0.160 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2017 | 3251 | 0.160 |
Why?
|
| Confidence Intervals | 10 | 2013 | 2910 | 0.160 |
Why?
|
| Models, Statistical | 6 | 2021 | 5089 | 0.160 |
Why?
|
| Glycemic Index | 4 | 2015 | 400 | 0.160 |
Why?
|
| Motivation | 5 | 2012 | 2018 | 0.160 |
Why?
|
| Genes, Mitochondrial | 1 | 2018 | 59 | 0.160 |
Why?
|
| Pyrophosphatases | 2 | 2010 | 141 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 2 | 2004 | 1612 | 0.150 |
Why?
|
| Urinary Retention | 1 | 1999 | 100 | 0.150 |
Why?
|
| Metabolome | 3 | 2016 | 1005 | 0.150 |
Why?
|
| Open Reading Frames | 1 | 2021 | 820 | 0.150 |
Why?
|
| ROC Curve | 5 | 2021 | 3620 | 0.150 |
Why?
|
| Health Services | 2 | 2016 | 756 | 0.150 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2010 | 204 | 0.150 |
Why?
|
| Abdominal Fat | 3 | 2010 | 217 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 5 | 2013 | 999 | 0.150 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 11888 | 0.150 |
Why?
|
| Natriuretic Peptide, Brain | 4 | 2010 | 1736 | 0.150 |
Why?
|
| Bayes Theorem | 3 | 2024 | 2354 | 0.150 |
Why?
|
| Pedigree | 7 | 2020 | 4526 | 0.150 |
Why?
|
| Monitoring, Immunologic | 1 | 1998 | 99 | 0.150 |
Why?
|
| Health Maintenance Organizations | 5 | 2007 | 656 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 506 | 0.150 |
Why?
|
| Mexico | 4 | 2021 | 777 | 0.150 |
Why?
|
| Time Factors | 17 | 2018 | 40065 | 0.150 |
Why?
|
| Fathers | 1 | 2000 | 376 | 0.140 |
Why?
|
| Taurine | 1 | 2018 | 91 | 0.140 |
Why?
|
| Risk Reduction Behavior | 3 | 2011 | 1123 | 0.140 |
Why?
|
| Weight Loss | 7 | 2022 | 2710 | 0.140 |
Why?
|
| Blood Coagulation Factors | 1 | 2000 | 371 | 0.140 |
Why?
|
| Metabolism | 1 | 2018 | 193 | 0.140 |
Why?
|
| Insurance, Health | 3 | 2010 | 2521 | 0.140 |
Why?
|
| Pericardium | 2 | 2014 | 679 | 0.140 |
Why?
|
| Receptors, Leptin | 2 | 2009 | 355 | 0.140 |
Why?
|
| Diet, Mediterranean | 3 | 2009 | 746 | 0.140 |
Why?
|
| Severity of Illness Index | 7 | 2021 | 15880 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2021 | 3230 | 0.140 |
Why?
|
| Young Adult | 23 | 2022 | 59889 | 0.140 |
Why?
|
| Neck | 2 | 2013 | 733 | 0.140 |
Why?
|
| Boston | 8 | 2018 | 9338 | 0.130 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 518 | 0.130 |
Why?
|
| Apolipoprotein B-100 | 2 | 2015 | 157 | 0.130 |
Why?
|
| Computational Biology | 5 | 2021 | 3559 | 0.130 |
Why?
|
| Hospitalization | 6 | 2022 | 10808 | 0.130 |
Why?
|
| Physician-Patient Relations | 3 | 2011 | 3278 | 0.130 |
Why?
|
| Phenylalanine | 1 | 2018 | 367 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 7 | 2010 | 2233 | 0.130 |
Why?
|
| Haplotypes | 4 | 2021 | 2728 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.130 |
Why?
|
| Patient Selection | 4 | 2009 | 4255 | 0.130 |
Why?
|
| Body Weight | 9 | 2014 | 4622 | 0.130 |
Why?
|
| Fatty Liver | 2 | 2014 | 807 | 0.130 |
Why?
|
| Dietary Sucrose | 3 | 2014 | 241 | 0.130 |
Why?
|
| Calcinosis | 3 | 2013 | 1479 | 0.130 |
Why?
|
| Reference Values | 9 | 2017 | 4908 | 0.130 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2016 | 291 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Algorithms | 8 | 2024 | 14071 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2016 | 1167 | 0.120 |
Why?
|
| Epigenesis, Genetic | 5 | 2023 | 3819 | 0.120 |
Why?
|
| Health Facilities | 1 | 2020 | 577 | 0.120 |
Why?
|
| Chemokines, CC | 1 | 2016 | 285 | 0.120 |
Why?
|
| Kidney Diseases | 3 | 2013 | 2098 | 0.120 |
Why?
|
| Meat Products | 1 | 2015 | 97 | 0.120 |
Why?
|
| Genetic Markers | 5 | 2023 | 2601 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2019 | 798 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2020 | 2424 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3797 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 2334 | 0.120 |
Why?
|
| Health Expenditures | 2 | 2017 | 2387 | 0.120 |
Why?
|
| Adult Children | 3 | 2013 | 104 | 0.120 |
Why?
|
| Tryptophan | 2 | 2021 | 483 | 0.120 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 248 | 0.120 |
Why?
|
| Least-Squares Analysis | 2 | 2016 | 368 | 0.120 |
Why?
|
| Glycine | 1 | 2018 | 672 | 0.120 |
Why?
|
| Meat | 2 | 2015 | 588 | 0.120 |
Why?
|
| Advisory Committees | 2 | 2009 | 796 | 0.110 |
Why?
|
| Milk | 2 | 2017 | 436 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2024 | 3446 | 0.110 |
Why?
|
| Genome | 1 | 2022 | 1753 | 0.110 |
Why?
|
| Disease Progression | 7 | 2024 | 13632 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2016 | 416 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2019 | 543 | 0.110 |
Why?
|
| Guideline Adherence | 3 | 2017 | 2243 | 0.110 |
Why?
|
| Syntaxin 1 | 1 | 2014 | 29 | 0.110 |
Why?
|
| Prognosis | 13 | 2024 | 29922 | 0.110 |
Why?
|
| R-SNARE Proteins | 1 | 2014 | 73 | 0.110 |
Why?
|
| Atrial Function | 1 | 2014 | 98 | 0.110 |
Why?
|
| Transcription Factors | 7 | 2023 | 12131 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 1084 | 0.110 |
Why?
|
| Nuclear Family | 2 | 2007 | 311 | 0.110 |
Why?
|
| Monitoring, Physiologic | 2 | 2020 | 1792 | 0.110 |
Why?
|
| Metformin | 4 | 2011 | 904 | 0.110 |
Why?
|
| Introns | 1 | 2016 | 966 | 0.110 |
Why?
|
| Spouses | 1 | 2016 | 288 | 0.110 |
Why?
|
| Adolescent | 23 | 2021 | 88835 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 869 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 3 | 2011 | 2172 | 0.110 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2010 | 45 | 0.110 |
Why?
|
| Flavonols | 1 | 2013 | 85 | 0.110 |
Why?
|
| Stress, Psychological | 3 | 2008 | 4533 | 0.100 |
Why?
|
| Homozygote | 3 | 2015 | 1775 | 0.100 |
Why?
|
| Nutrition Policy | 2 | 2007 | 467 | 0.100 |
Why?
|
| Databases, Genetic | 3 | 2021 | 1751 | 0.100 |
Why?
|
| Chronic Disease | 4 | 2024 | 9347 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 2013 | 2817 | 0.100 |
Why?
|
| Nutrition Assessment | 2 | 2014 | 738 | 0.100 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 5508 | 0.100 |
Why?
|
| Intensive Care Units | 3 | 2021 | 3800 | 0.100 |
Why?
|
| Genetic Pleiotropy | 1 | 2014 | 182 | 0.100 |
Why?
|
| Italy | 4 | 2011 | 854 | 0.100 |
Why?
|
| Lipoproteins | 3 | 2003 | 866 | 0.100 |
Why?
|
| Integrin alpha1 | 1 | 2012 | 13 | 0.100 |
Why?
|
| Body Height | 3 | 2015 | 1562 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2004 | 2517 | 0.100 |
Why?
|
| Comorbidity | 9 | 2020 | 10563 | 0.100 |
Why?
|
| Food | 1 | 2017 | 764 | 0.100 |
Why?
|
| Europe | 5 | 2020 | 3423 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2022 | 1597 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1529 | 0.100 |
Why?
|
| Apolipoprotein C-I | 1 | 2011 | 14 | 0.100 |
Why?
|
| Energy Intake | 8 | 2014 | 2141 | 0.100 |
Why?
|
| Vitamin K 1 | 2 | 2009 | 41 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2003 | 274 | 0.100 |
Why?
|
| Urbanization | 1 | 2012 | 101 | 0.100 |
Why?
|
| Anorexia Nervosa | 1 | 2021 | 1328 | 0.100 |
Why?
|
| Causality | 4 | 2022 | 1248 | 0.100 |
Why?
|
| Bone Density | 3 | 2014 | 3491 | 0.100 |
Why?
|
| Dietary Carbohydrates | 2 | 2009 | 894 | 0.100 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 7875 | 0.090 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 261 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 1192 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 871 | 0.090 |
Why?
|
| High Mobility Group Proteins | 1 | 2012 | 180 | 0.090 |
Why?
|
| Heart Failure | 3 | 2013 | 11840 | 0.090 |
Why?
|
| Exercise | 7 | 2012 | 5937 | 0.090 |
Why?
|
| PPAR gamma | 2 | 2012 | 483 | 0.090 |
Why?
|
| Phospholipase C gamma | 1 | 2011 | 130 | 0.090 |
Why?
|
| Trace Elements | 1 | 2013 | 193 | 0.090 |
Why?
|
| Texas | 2 | 2003 | 410 | 0.090 |
Why?
|
| RANK Ligand | 1 | 2013 | 319 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 2017 | 874 | 0.090 |
Why?
|
| Epigenomics | 3 | 2024 | 959 | 0.090 |
Why?
|
| Retrospective Studies | 23 | 2023 | 81514 | 0.090 |
Why?
|
| Lipid Metabolism | 2 | 2021 | 1892 | 0.090 |
Why?
|
| Phosphate Transport Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Menopause, Premature | 1 | 1992 | 124 | 0.090 |
Why?
|
| Cotinine | 1 | 2011 | 206 | 0.090 |
Why?
|
| Laminin | 1 | 2012 | 404 | 0.090 |
Why?
|
| Calcium Channels | 1 | 2014 | 622 | 0.090 |
Why?
|
| Health Care Costs | 2 | 2018 | 3242 | 0.090 |
Why?
|
| Costs and Cost Analysis | 2 | 2006 | 1668 | 0.090 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 52 | 0.090 |
Why?
|
| Diabetic Nephropathies | 3 | 2024 | 969 | 0.090 |
Why?
|
| Data Collection | 4 | 2010 | 3318 | 0.080 |
Why?
|
| Mothers | 1 | 2000 | 2210 | 0.080 |
Why?
|
| Endpoint Determination | 1 | 2013 | 591 | 0.080 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2005 | 694 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 1946 | 0.080 |
Why?
|
| Liver | 5 | 2021 | 7562 | 0.080 |
Why?
|
| Antipsychotic Agents | 1 | 2023 | 3076 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 4392 | 0.080 |
Why?
|
| Sex Characteristics | 7 | 2021 | 2643 | 0.080 |
Why?
|
| Calcification, Physiologic | 1 | 2010 | 166 | 0.080 |
Why?
|
| Factor VII | 1 | 2010 | 139 | 0.080 |
Why?
|
| Anthropometry | 4 | 2018 | 1338 | 0.080 |
Why?
|
| Osteoporosis | 3 | 2014 | 1582 | 0.080 |
Why?
|
| Speech Recognition Software | 1 | 2010 | 74 | 0.080 |
Why?
|
| Dietary Supplements | 3 | 2013 | 3425 | 0.080 |
Why?
|
| Lipodystrophy | 2 | 2001 | 145 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1410 | 0.080 |
Why?
|
| Atrial Function, Left | 1 | 2011 | 189 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 1365 | 0.080 |
Why?
|
| Age of Onset | 4 | 2013 | 3344 | 0.080 |
Why?
|
| Depression | 5 | 2008 | 8237 | 0.080 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2008 | 357 | 0.080 |
Why?
|
| Ambulatory Care | 4 | 2021 | 2778 | 0.080 |
Why?
|
| Sample Size | 3 | 2021 | 845 | 0.080 |
Why?
|
| Lipase | 2 | 2022 | 320 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1748 | 0.080 |
Why?
|
| Receptors, Cannabinoid | 1 | 2009 | 43 | 0.080 |
Why?
|
| Receptors, Melatonin | 1 | 2008 | 31 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.080 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 8730 | 0.080 |
Why?
|
| Aorta, Thoracic | 2 | 2012 | 1103 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2019 | 6255 | 0.080 |
Why?
|
| Osteocalcin | 1 | 2009 | 271 | 0.080 |
Why?
|
| Hip | 1 | 2010 | 249 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2011 | 1396 | 0.080 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 325 | 0.080 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 1053 | 0.080 |
Why?
|
| Medicine | 2 | 2009 | 942 | 0.080 |
Why?
|
| Heart Conduction System | 1 | 2014 | 1006 | 0.080 |
Why?
|
| Community-Institutional Relations | 1 | 2010 | 209 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2453 | 0.070 |
Why?
|
| Actinin | 2 | 1986 | 165 | 0.070 |
Why?
|
| Social Class | 4 | 2020 | 2007 | 0.070 |
Why?
|
| Amidohydrolases | 1 | 2009 | 162 | 0.070 |
Why?
|
| Communication | 3 | 2024 | 3916 | 0.070 |
Why?
|
| Gene Dosage | 2 | 2010 | 1216 | 0.070 |
Why?
|
| Intermittent Claudication | 1 | 2010 | 300 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 4772 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2013 | 959 | 0.070 |
Why?
|
| Interleukin-18 | 1 | 2009 | 251 | 0.070 |
Why?
|
| Factor VIII | 1 | 2010 | 347 | 0.070 |
Why?
|
| Dietary Fiber | 3 | 2006 | 767 | 0.070 |
Why?
|
| Environment | 2 | 2011 | 1114 | 0.070 |
Why?
|
| Patients | 2 | 2009 | 910 | 0.070 |
Why?
|
| Professional Practice | 1 | 2009 | 313 | 0.070 |
Why?
|
| Sensitivity and Specificity | 6 | 2021 | 14652 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 2975 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2010 | 516 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2005 | 1657 | 0.070 |
Why?
|
| Privacy | 1 | 2009 | 233 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 675 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 854 | 0.070 |
Why?
|
| Viral Load | 3 | 2012 | 3386 | 0.070 |
Why?
|
| Dinoprost | 1 | 2007 | 139 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2024 | 3584 | 0.070 |
Why?
|
| Motor Activity | 3 | 2012 | 2704 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 933 | 0.070 |
Why?
|
| Probability | 3 | 2013 | 2475 | 0.070 |
Why?
|
| Adipose Tissue, White | 1 | 2009 | 370 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2011 | 824 | 0.070 |
Why?
|
| Alcohol Drinking | 6 | 2013 | 4040 | 0.070 |
Why?
|
| Urban Population | 2 | 2012 | 2040 | 0.070 |
Why?
|
| Diet Surveys | 5 | 2012 | 1159 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2012 | 870 | 0.070 |
Why?
|
| Hyperemia | 1 | 2008 | 224 | 0.070 |
Why?
|
| Phorbols | 1 | 1986 | 44 | 0.070 |
Why?
|
| Telephone | 1 | 2010 | 627 | 0.070 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 1415 | 0.070 |
Why?
|
| Informatics | 1 | 2006 | 71 | 0.070 |
Why?
|
| Anti-HIV Agents | 4 | 2012 | 4559 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2005 | 1132 | 0.070 |
Why?
|
| Ghrelin | 1 | 2008 | 255 | 0.070 |
Why?
|
| Baltimore | 2 | 2004 | 232 | 0.070 |
Why?
|
| Sodium | 3 | 2006 | 1591 | 0.060 |
Why?
|
| Iron | 2 | 2005 | 1816 | 0.060 |
Why?
|
| Brain Ischemia | 2 | 2011 | 3000 | 0.060 |
Why?
|
| Membrane Proteins | 4 | 2022 | 7851 | 0.060 |
Why?
|
| Bipolar Disorder | 1 | 2023 | 5138 | 0.060 |
Why?
|
| Brachial Artery | 1 | 2008 | 375 | 0.060 |
Why?
|
| Vitamin K | 1 | 2008 | 312 | 0.060 |
Why?
|
| Serum Albumin | 1 | 2009 | 675 | 0.060 |
Why?
|
| Models, Biological | 7 | 2013 | 9443 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7425 | 0.060 |
Why?
|
| Homeodomain Proteins | 4 | 2023 | 2428 | 0.060 |
Why?
|
| Molecular Weight | 3 | 2016 | 2163 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 273 | 0.060 |
Why?
|
| Chromans | 1 | 2005 | 116 | 0.060 |
Why?
|
| Cognition | 2 | 2015 | 7049 | 0.060 |
Why?
|
| Drug Prescriptions | 2 | 2005 | 1662 | 0.060 |
Why?
|
| Fruit | 2 | 2009 | 1166 | 0.060 |
Why?
|
| Mitochondria | 1 | 2018 | 3673 | 0.060 |
Why?
|
| Body Constitution | 4 | 2004 | 272 | 0.060 |
Why?
|
| Iodide Peroxidase | 1 | 2007 | 297 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2009 | 682 | 0.060 |
Why?
|
| Lisinopril | 1 | 2005 | 60 | 0.060 |
Why?
|
| Administration, Oral | 3 | 2009 | 4015 | 0.060 |
Why?
|
| Animals | 14 | 2019 | 168764 | 0.060 |
Why?
|
| Hydrochlorothiazide | 1 | 2005 | 95 | 0.060 |
Why?
|
| Atenolol | 1 | 2005 | 99 | 0.060 |
Why?
|
| Genetics, Population | 3 | 2021 | 943 | 0.060 |
Why?
|
| Retreatment | 1 | 2006 | 598 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1986 | 822 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 297 | 0.060 |
Why?
|
| Health Status | 4 | 2018 | 4080 | 0.060 |
Why?
|
| Natriuresis | 1 | 2004 | 106 | 0.060 |
Why?
|
| England | 2 | 2019 | 533 | 0.060 |
Why?
|
| Prostatic Neoplasms | 2 | 1998 | 11083 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2004 | 855 | 0.060 |
Why?
|
| Adipocytes | 2 | 2024 | 1194 | 0.060 |
Why?
|
| International Classification of Diseases | 2 | 2024 | 935 | 0.060 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 3928 | 0.060 |
Why?
|
| Quality of Life | 1 | 2006 | 13462 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2004 | 107 | 0.060 |
Why?
|
| Fractures, Ununited | 1 | 2006 | 176 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6832 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 20124 | 0.060 |
Why?
|
| Atrial Fibrillation | 3 | 2014 | 5189 | 0.060 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2007 | 475 | 0.060 |
Why?
|
| Femoral Fractures | 1 | 2007 | 375 | 0.050 |
Why?
|
| Air Pollution | 1 | 2017 | 2380 | 0.050 |
Why?
|
| Sex Distribution | 3 | 2018 | 2263 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2005 | 2780 | 0.050 |
Why?
|
| Kidney | 4 | 2022 | 7066 | 0.050 |
Why?
|
| Puberty | 1 | 2007 | 491 | 0.050 |
Why?
|
| Trans Fatty Acids | 1 | 2005 | 155 | 0.050 |
Why?
|
| Air Pollutants | 1 | 2017 | 2923 | 0.050 |
Why?
|
| Vasodilation | 1 | 2008 | 970 | 0.050 |
Why?
|
| Child | 12 | 2024 | 80564 | 0.050 |
Why?
|
| Population Surveillance | 2 | 2011 | 2590 | 0.050 |
Why?
|
| Exercise Tolerance | 1 | 2008 | 841 | 0.050 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 23 | 0.050 |
Why?
|
| Insulysin | 1 | 2003 | 49 | 0.050 |
Why?
|
| Renin | 3 | 2010 | 647 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2012 | 1175 | 0.050 |
Why?
|
| Advance Care Planning | 1 | 2011 | 702 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 1272 | 0.050 |
Why?
|
| Likelihood Functions | 2 | 2016 | 993 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 2 | 2018 | 1787 | 0.050 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2016 | 103 | 0.050 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2004 | 353 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2011 | 1159 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 2024 | 79 | 0.050 |
Why?
|
| Cystatin C | 3 | 2010 | 272 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 2003 | 87 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2014 | 2648 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2005 | 451 | 0.050 |
Why?
|
| Finland | 2 | 2017 | 608 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2016 | 2587 | 0.050 |
Why?
|
| Perception | 1 | 2009 | 1205 | 0.050 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 429 | 0.050 |
Why?
|
| Endothelium | 1 | 2005 | 767 | 0.050 |
Why?
|
| Tibial Fractures | 1 | 2006 | 276 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 4 | 2008 | 5786 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 2 | 2012 | 939 | 0.050 |
Why?
|
| Syndrome | 2 | 2000 | 3271 | 0.050 |
Why?
|
| DNA | 3 | 2013 | 7202 | 0.050 |
Why?
|
| Registries | 6 | 2013 | 8297 | 0.050 |
Why?
|
| Abdomen | 3 | 2020 | 1134 | 0.050 |
Why?
|
| Fats | 1 | 2003 | 99 | 0.050 |
Why?
|
| Ferritins | 2 | 2022 | 600 | 0.050 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2005 | 347 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 459 | 0.050 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9525 | 0.050 |
Why?
|
| Caffeine | 2 | 2007 | 702 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2005 | 568 | 0.050 |
Why?
|
| Quality of Health Care | 3 | 2006 | 4300 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 852 | 0.050 |
Why?
|
| Drug Utilization Review | 1 | 2003 | 248 | 0.050 |
Why?
|
| Alanine | 2 | 2003 | 612 | 0.050 |
Why?
|
| Treatment Outcome | 9 | 2022 | 65188 | 0.050 |
Why?
|
| Health Services Research | 3 | 2004 | 1808 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1892 | 0.050 |
Why?
|
| Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
| Education, Continuing | 1 | 2002 | 115 | 0.050 |
Why?
|
| Apolipoproteins C | 1 | 2001 | 58 | 0.050 |
Why?
|
| Prostatitis | 1 | 2002 | 102 | 0.050 |
Why?
|
| Antidepressive Agents | 2 | 2004 | 2897 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2010 | 10070 | 0.050 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 1874 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 1899 | 0.050 |
Why?
|
| Pregnancy | 4 | 2023 | 30260 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2020 | 2900 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2006 | 747 | 0.050 |
Why?
|
| Goals | 1 | 2006 | 719 | 0.050 |
Why?
|
| Lactase | 1 | 2021 | 72 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2013 | 175 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 183 | 0.050 |
Why?
|
| Family Practice | 1 | 2004 | 508 | 0.050 |
Why?
|
| Hyperaldosteronism | 1 | 2004 | 252 | 0.040 |
Why?
|
| Blood Sedimentation | 1 | 2022 | 233 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 4697 | 0.040 |
Why?
|
| Pharmacists | 1 | 2003 | 260 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2008 | 1950 | 0.040 |
Why?
|
| Lysophospholipase | 1 | 2020 | 65 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 1986 | 1158 | 0.040 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2020 | 58 | 0.040 |
Why?
|
| Kynurenine | 1 | 2021 | 142 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
| Isoelectric Focusing | 1 | 2000 | 148 | 0.040 |
Why?
|
| Organ Size | 3 | 2012 | 2260 | 0.040 |
Why?
|
| Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2012 | 2060 | 0.040 |
Why?
|
| Radiography | 4 | 2014 | 6919 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2021 | 8067 | 0.040 |
Why?
|
| Blood Flow Velocity | 3 | 2009 | 1381 | 0.040 |
Why?
|
| Telomere | 1 | 2006 | 943 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2012 | 2041 | 0.040 |
Why?
|
| Hospitals, General | 2 | 2020 | 802 | 0.040 |
Why?
|
| California | 1 | 2024 | 1436 | 0.040 |
Why?
|
| Attitude of Health Personnel | 2 | 2004 | 3925 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2011 | 4058 | 0.040 |
Why?
|
| Eating | 2 | 2023 | 1540 | 0.040 |
Why?
|
| Hypolipidemic Agents | 2 | 2005 | 608 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3807 | 0.040 |
Why?
|
| Research Design | 2 | 2016 | 6209 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 268 | 0.040 |
Why?
|
| Treatment Refusal | 1 | 2003 | 433 | 0.040 |
Why?
|
| Mortality | 2 | 2009 | 2904 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2012 | 6499 | 0.040 |
Why?
|
| Indians, North American | 2 | 2013 | 354 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2022 | 428 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 1275 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 784 | 0.040 |
Why?
|
| Blood Viscosity | 1 | 2000 | 125 | 0.040 |
Why?
|
| Gene Expression | 3 | 2021 | 7584 | 0.040 |
Why?
|
| Penetrance | 1 | 2021 | 388 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2003 | 469 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 1 | 2000 | 198 | 0.040 |
Why?
|
| Cytokines | 1 | 2014 | 7421 | 0.040 |
Why?
|
| Environmental Exposure | 2 | 2014 | 4544 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2005 | 1365 | 0.040 |
Why?
|
| Specialization | 1 | 2004 | 777 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 1514 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 601 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 1432 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2000 | 331 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 298 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2001 | 532 | 0.040 |
Why?
|
| Coffee | 1 | 1983 | 593 | 0.040 |
Why?
|
| Leukocytes | 1 | 2006 | 2027 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2020 | 319 | 0.040 |
Why?
|
| Kidney Function Tests | 2 | 2010 | 683 | 0.040 |
Why?
|
| Bangladesh | 1 | 2020 | 745 | 0.040 |
Why?
|
| rho-Associated Kinases | 1 | 2020 | 291 | 0.040 |
Why?
|
| Cystatins | 2 | 2008 | 55 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2001 | 677 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 837 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3965 | 0.040 |
Why?
|
| Butter | 1 | 2017 | 22 | 0.040 |
Why?
|
| Heterozygote | 2 | 2021 | 2794 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2022 | 1602 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2017 | 128 | 0.040 |
Why?
|
| Age Distribution | 2 | 2018 | 2858 | 0.040 |
Why?
|
| Cheese | 1 | 2017 | 39 | 0.040 |
Why?
|
| Osmolar Concentration | 2 | 2012 | 655 | 0.040 |
Why?
|
| Physicians, Primary Care | 1 | 2024 | 622 | 0.040 |
Why?
|
| Prehypertension | 1 | 2018 | 63 | 0.040 |
Why?
|
| Health Resources | 1 | 2004 | 949 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2011 | 10383 | 0.040 |
Why?
|
| Stem Cells | 1 | 2010 | 3540 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2003 | 1187 | 0.030 |
Why?
|
| Parents | 1 | 2011 | 3592 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2007 | 1416 | 0.030 |
Why?
|
| Nurses | 2 | 2004 | 2505 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2008 | 3096 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2021 | 1228 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3596 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2006 | 2352 | 0.030 |
Why?
|
| Sulfates | 1 | 2017 | 376 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2010 | 2796 | 0.030 |
Why?
|
| Echocardiography | 2 | 2011 | 5045 | 0.030 |
Why?
|
| Health Education | 1 | 2003 | 1060 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 41 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 1707 | 0.030 |
Why?
|
| Epidemiologic Factors | 1 | 1996 | 36 | 0.030 |
Why?
|
| China | 2 | 2013 | 2385 | 0.030 |
Why?
|
| Family | 2 | 2004 | 3209 | 0.030 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2016 | 48 | 0.030 |
Why?
|
| Soot | 1 | 2017 | 219 | 0.030 |
Why?
|
| Community Health Services | 2 | 2011 | 657 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 52 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2022 | 1530 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2016 | 108 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2017 | 360 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2016 | 92 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 50 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2017 | 42500 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2012 | 20659 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2007 | 2660 | 0.030 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 2003 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2008 | 3714 | 0.030 |
Why?
|
| Colon | 1 | 2023 | 1795 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2016 | 187 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2022 | 1343 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 138 | 0.030 |
Why?
|
| Inpatients | 1 | 2007 | 2564 | 0.030 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Survival Rate | 3 | 2018 | 12795 | 0.030 |
Why?
|
| Demography | 2 | 2013 | 1641 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 184 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2015 | 90 | 0.030 |
Why?
|
| Immunoassay | 1 | 1998 | 741 | 0.030 |
Why?
|
| Infant | 4 | 2022 | 36386 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2022 | 3050 | 0.030 |
Why?
|
| CpG Islands | 1 | 2019 | 1207 | 0.030 |
Why?
|
| Binding Sites | 2 | 2015 | 6001 | 0.030 |
Why?
|
| Acute Disease | 2 | 2009 | 7232 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2001 | 970 | 0.030 |
Why?
|
| Folic Acid | 1 | 2001 | 1338 | 0.030 |
Why?
|
| Cause of Death | 2 | 2016 | 3708 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 586 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 381 | 0.030 |
Why?
|
| Hypertriglyceridemia | 2 | 2007 | 290 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2058 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2016 | 12768 | 0.030 |
Why?
|
| Heart Ventricles | 2 | 2004 | 3832 | 0.030 |
Why?
|
| Brain | 3 | 2012 | 27171 | 0.030 |
Why?
|
| Ozone | 1 | 2017 | 499 | 0.030 |
Why?
|
| Housing | 2 | 2017 | 683 | 0.030 |
Why?
|
| Residence Characteristics | 2 | 2017 | 2116 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2018 | 647 | 0.030 |
Why?
|
| Alpha-Globulins | 1 | 2013 | 26 | 0.030 |
Why?
|
| Proteins | 2 | 2010 | 5995 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 3202 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 93 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1968 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 2014 | 2077 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2013 | 126 | 0.030 |
Why?
|
| Mucin-3 | 1 | 2012 | 6 | 0.030 |
Why?
|
| Menopause | 3 | 2006 | 1659 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2017 | 651 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 857 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 938 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 3946 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 703 | 0.030 |
Why?
|
| Cell Line | 3 | 2013 | 15543 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 792 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1311 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2535 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 10729 | 0.020 |
Why?
|
| Treatment Failure | 2 | 2010 | 2652 | 0.020 |
Why?
|
| Counseling | 1 | 2000 | 1551 | 0.020 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2013 | 170 | 0.020 |
Why?
|
| Chromatin | 1 | 2024 | 2980 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2880 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 1 | 2012 | 98 | 0.020 |
Why?
|
| Random Allocation | 1 | 1996 | 2395 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 139 | 0.020 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 2966 | 0.020 |
Why?
|
| Social Marketing | 1 | 2011 | 51 | 0.020 |
Why?
|
| Vegetables | 2 | 2009 | 1199 | 0.020 |
Why?
|
| Diet Records | 1 | 2013 | 425 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 1992 | 134 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 643 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Pakistan | 1 | 2012 | 300 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2012 | 165 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2017 | 1470 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2011 | 143 | 0.020 |
Why?
|
| Guidelines as Topic | 2 | 2007 | 1394 | 0.020 |
Why?
|
| Vitamins | 2 | 2009 | 1630 | 0.020 |
Why?
|
| Exercise Test | 1 | 2018 | 2180 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1983 | 2176 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2020 | 5379 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2589 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 708 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2014 | 674 | 0.020 |
Why?
|
| Bacteria | 1 | 2021 | 2209 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3432 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2011 | 171 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2011 | 317 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2012 | 328 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1828 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 1014 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2017 | 1187 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2008 | 978 | 0.020 |
Why?
|
| Length of Stay | 1 | 2004 | 6485 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 116 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2013 | 651 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2010 | 102 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 390 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2021 | 1723 | 0.020 |
Why?
|
| Connecticut | 4 | 1983 | 365 | 0.020 |
Why?
|
| Organizations, Nonprofit | 1 | 2010 | 105 | 0.020 |
Why?
|
| Reminder Systems | 1 | 2012 | 388 | 0.020 |
Why?
|
| Endonucleases | 1 | 2012 | 372 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1072 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 4808 | 0.020 |
Why?
|
| Skinfold Thickness | 2 | 1971 | 164 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3607 | 0.020 |
Why?
|
| Software | 1 | 2003 | 4462 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2709 | 0.020 |
Why?
|
| Incretins | 1 | 2010 | 100 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5302 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3564 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2012 | 444 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3910 | 0.020 |
Why?
|
| Genes | 1 | 2012 | 1825 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2011 | 840 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2011 | 812 | 0.020 |
Why?
|
| Metagenomics | 1 | 2012 | 473 | 0.020 |
Why?
|
| Physicians | 2 | 2003 | 4588 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2009 | 318 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4913 | 0.020 |
Why?
|
| Hormones | 1 | 2012 | 863 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1992 | 540 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 2012 | 623 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1078 | 0.020 |
Why?
|
| Mice | 4 | 2019 | 81819 | 0.020 |
Why?
|
| Mutation | 3 | 2023 | 30198 | 0.020 |
Why?
|
| Femur | 1 | 2014 | 1310 | 0.020 |
Why?
|
| Critical Illness | 1 | 2021 | 2744 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4108 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2006 | 6972 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2014 | 6404 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 452 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1140 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 774 | 0.020 |
Why?
|
| Spine | 1 | 2014 | 1128 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2011 | 777 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 955 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 4958 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2009 | 224 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3586 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1130 | 0.020 |
Why?
|
| Sucrose | 1 | 2007 | 155 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5343 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2012 | 1188 | 0.020 |
Why?
|
| Veterans | 1 | 2020 | 2664 | 0.020 |
Why?
|
| Blood Circulation | 1 | 2007 | 248 | 0.020 |
Why?
|
| Osteoprotegerin | 1 | 2007 | 178 | 0.020 |
Why?
|
| Epidemiologic Methods | 2 | 2009 | 1326 | 0.020 |
Why?
|
| Vinculin | 1 | 1986 | 58 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1314 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 5743 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 9601 | 0.020 |
Why?
|
| Thorax | 1 | 2009 | 554 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2017 | 2624 | 0.020 |
Why?
|
| Rhodamines | 1 | 1986 | 178 | 0.020 |
Why?
|
| Manometry | 1 | 2008 | 457 | 0.020 |
Why?
|
| HIV | 1 | 2012 | 1585 | 0.020 |
Why?
|
| Albumins | 1 | 2008 | 577 | 0.020 |
Why?
|
| Vulvar Neoplasms | 2 | 1958 | 270 | 0.020 |
Why?
|
| Microinjections | 1 | 1986 | 320 | 0.020 |
Why?
|
| Calcium | 2 | 2009 | 5767 | 0.020 |
Why?
|
| Femoral Artery | 1 | 2009 | 811 | 0.010 |
Why?
|
| Internationality | 1 | 2010 | 1007 | 0.010 |
Why?
|
| Siblings | 1 | 2009 | 828 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2009 | 929 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1988 | 379 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2014 | 4137 | 0.010 |
Why?
|
| Glycerides | 1 | 1964 | 67 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1526 | 0.010 |
Why?
|
| Cholecalciferol | 1 | 2009 | 550 | 0.010 |
Why?
|
| Heart | 2 | 2016 | 4414 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2485 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 1976 | 1938 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1992 | 1383 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2850 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2012 | 1620 | 0.010 |
Why?
|
| Chickens | 1 | 1986 | 842 | 0.010 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2005 | 167 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2011 | 937 | 0.010 |
Why?
|
| RNA Interference | 1 | 2012 | 2832 | 0.010 |
Why?
|
| Vasculitis | 1 | 2008 | 527 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2007 | 841 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 1195 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14448 | 0.010 |
Why?
|
| Morbidity | 1 | 2009 | 1749 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4260 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1740 | 0.010 |
Why?
|
| Emigrants and Immigrants | 1 | 2010 | 549 | 0.010 |
Why?
|
| Pinocytosis | 1 | 1983 | 64 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 2005 | 384 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1986 | 564 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 538 | 0.010 |
Why?
|
| Diuretics | 1 | 2006 | 613 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2003 | 83 | 0.010 |
Why?
|
| Reproduction | 1 | 1988 | 641 | 0.010 |
Why?
|
| Abdominal Wall | 1 | 1964 | 166 | 0.010 |
Why?
|
| Arteries | 1 | 2008 | 1118 | 0.010 |
Why?
|
| Monocytes | 1 | 2012 | 2595 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 2003 | 123 | 0.010 |
Why?
|
| Hemoglobinometry | 1 | 2002 | 35 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1988 | 704 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3690 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12403 | 0.010 |
Why?
|
| Myocardium | 2 | 1985 | 4760 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2004 | 300 | 0.010 |
Why?
|
| Forearm | 1 | 1964 | 427 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1986 | 931 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2013 | 4493 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 453 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 2014 | 18973 | 0.010 |
Why?
|
| Iron Overload | 1 | 2004 | 245 | 0.010 |
Why?
|
| Peptides | 1 | 2013 | 4331 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 591 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 507 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 2007 | 906 | 0.010 |
Why?
|
| Medical Records | 1 | 2007 | 1409 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2045 | 0.010 |
Why?
|
| Fishes | 1 | 2004 | 606 | 0.010 |
Why?
|
| Minority Groups | 1 | 2008 | 1207 | 0.010 |
Why?
|
| Patient Participation | 1 | 2010 | 1455 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1985 | 1178 | 0.010 |
Why?
|
| Threonine | 1 | 2001 | 272 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2004 | 5993 | 0.010 |
Why?
|
| Bulimia | 1 | 2002 | 404 | 0.010 |
Why?
|
| Delivery of Health Care | 2 | 2014 | 5370 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 2001 | 209 | 0.010 |
Why?
|
| Self Report | 1 | 2011 | 3770 | 0.010 |
Why?
|
| Health Promotion | 1 | 2011 | 2208 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1986 | 3089 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2686 | 0.010 |
Why?
|
| Public Health | 1 | 2012 | 2680 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 2002 | 487 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 1631 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1983 | 2477 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2005 | 1247 | 0.010 |
Why?
|
| HIV Protease Inhibitors | 1 | 2000 | 430 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2007 | 2864 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1718 | 0.010 |
Why?
|
| Research | 1 | 2006 | 1975 | 0.010 |
Why?
|
| Rats | 1 | 2014 | 23707 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1985 | 4159 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2017 | 26346 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2005 | 1820 | 0.010 |
Why?
|
| Women's Health | 1 | 2007 | 2084 | 0.010 |
Why?
|
| Lysosomes | 1 | 1983 | 932 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6203 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1983 | 1520 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 5783 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2005 | 1051 | 0.010 |
Why?
|
| Actins | 1 | 1985 | 2056 | 0.010 |
Why?
|
| Skin | 1 | 1971 | 4489 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2892 | 0.010 |
Why?
|
| Heart Atria | 1 | 2003 | 1363 | 0.010 |
Why?
|
| Carcinoma | 2 | 1958 | 2312 | 0.010 |
Why?
|
| Water Supply | 1 | 1978 | 204 | 0.010 |
Why?
|
| Lead | 1 | 1982 | 879 | 0.010 |
Why?
|
| Asbestos | 1 | 1978 | 250 | 0.010 |
Why?
|
| Thrombosis | 1 | 2010 | 2949 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 22332 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 17075 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2128 | 0.010 |
Why?
|
| Estrogens | 1 | 1982 | 1529 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2005 | 1940 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 2936 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2001 | 1206 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8733 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6069 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2008 | 12437 | 0.010 |
Why?
|
| Vaginal Neoplasms | 1 | 1954 | 104 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1976 | 1600 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2001 | 1806 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1982 | 1421 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2004 | 4025 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1985 | 964 | 0.010 |
Why?
|
| Menstruation | 1 | 1954 | 309 | 0.010 |
Why?
|
| Pediatrics | 1 | 1988 | 3606 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1958 | 4044 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 36532 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8529 | 0.010 |
Why?
|
| Postmenopause | 1 | 2001 | 2515 | 0.010 |
Why?
|
| Atlantic Islands | 1 | 1971 | 3 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1988 | 4274 | 0.010 |
Why?
|
| Uterus | 1 | 1954 | 661 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1978 | 961 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 5526 | 0.010 |
Why?
|
| HIV-1 | 1 | 2007 | 6944 | 0.010 |
Why?
|
| Thinness | 1 | 1971 | 482 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 2 | 1985 | 2627 | 0.000 |
Why?
|
| Kinetics | 2 | 1985 | 6274 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12976 | 0.000 |
Why?
|
| Menstruation Disturbances | 1 | 1988 | 139 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2010 | 23601 | 0.000 |
Why?
|
| Endometriosis | 1 | 1954 | 870 | 0.000 |
Why?
|
| Myofibrils | 1 | 1985 | 143 | 0.000 |
Why?
|
| Amoeba | 1 | 1983 | 20 | 0.000 |
Why?
|
| Wounds and Injuries | 1 | 1976 | 2511 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1976 | 3615 | 0.000 |
Why?
|
| Vesicovaginal Fistula | 1 | 1962 | 10 | 0.000 |
Why?
|
| Ribonucleases | 1 | 1983 | 265 | 0.000 |
Why?
|
| Intracellular Membranes | 1 | 1983 | 386 | 0.000 |
Why?
|
| Urinary Calculi | 1 | 1962 | 81 | 0.000 |
Why?
|
| Membrane Fusion | 1 | 1983 | 264 | 0.000 |
Why?
|
| Urinary Bladder Diseases | 1 | 1962 | 166 | 0.000 |
Why?
|
| Urination Disorders | 1 | 1962 | 236 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1983 | 574 | 0.000 |
Why?
|
| Hysterectomy | 1 | 1962 | 864 | 0.000 |
Why?
|
| Family Characteristics | 1 | 1982 | 1001 | 0.000 |
Why?
|
| Carcinoma in Situ | 1 | 1982 | 779 | 0.000 |
Why?
|
| Hypotension | 1 | 1961 | 885 | 0.000 |
Why?
|
| Protein Binding | 1 | 1985 | 9296 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1962 | 2047 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1988 | 9071 | 0.000 |
Why?
|